This compound is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of active pharmaceutical ingredients (APIs). It plays a crucial role in the development of drugs targeting specific receptors, particularly in the treatment of conditions related to the central nervous system. Its structural features, including the trifluoromethyl group, enhance the bioavailability and metabolic stability of the resulting drugs. Additionally, it is employed in research settings to study the pharmacological properties of chiral compounds, aiding in the design of more effective and selective therapeutic agents.